Public Alert No.0037/2021- Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi® (Amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination
, Dear Healthcare Provider, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by U.S Food and drug Administration (FDA) that Jacobus Pharmaceutical Company Inc. is voluntarily recalling 3 lots of Ruzurgi® (Amifampridine) 10 mg tablets to the consumer level. The products were found to be contaminated with yeast, mold, and […]
Public Alert No: 037/2021 – Baxter Issues Urgent Medical Device Correction for All Spectrum IQ Infusion Pumps to Reinforce Important Safety Information Regarding Best Practices for Customer-Initiated IT Network Updates
, The National Agency for Food and Drug Administration and Control (NAFDAC) has been informed by U.S Food and drug administration (FDA) about a safety communication that Baxter International Inc. has issued an Urgent Medical Device Correction for all Spectrum IQ infusion pumps to reinforce important safety information when customers implement changes to their network […]
